Missing
(N=50)
PD-L1 TPS
(N=42)
P-value
Age(years)
Mean (SD) 62.9 (8.28) 63.8 (7.51) 0.507
Median [Min, Max] 65.0 [35.0, 75.0] 64.5 [47.0, 76.0]
Sex
FeMale 6 (12.0%) 4 (9.5%) 0.965
Male 44 (88.0%) 38 (90.5%)
Smoking
No 12 (24.0%) 4 (9.5%) 0.121
Yes 38 (76.0%) 38 (90.5%)
Pathologic subtype
Non squamous 22 (44.0%) 26 (61.9%) 0.133
Squamous 28 (56.0%) 16 (38.1%)
PFS(months)
Mean (SD) 12.7 (9.50) 18.5 (11.0) 0.421
Median [Min, Max] 9.80 [1.47, 36.9] 18.7 [0.600, 37.4]
OS(months)
Mean (SD) 18.9 (11.3) 22.9 (9.59) 0.392
Median [Min, Max] 18.7 [1.47, 38.3] 24.2 [1.33, 39.3]
Clinical benefit
DCB 36 (72.0%) 33 (78.6%) 0.629
NDB 14 (28.0%) 9 (21.4%)
LDH
Mean (SD) 273 (195) 203 (93.3) 0.319
Median [Min, Max] 207 [119, 1110] 180 [66.7, 560]
Missing 1 (2.0%) 0 (0%)
NLR
Mean (SD) 4.33 (2.16) 3.26 (1.77) 0.362
Median [Min, Max] 3.72 [1.04, 9.80] 2.90 [1.25, 8.79]
Bone metastasis
No 31 (62.0%) 28 (66.7%) 0.805
Yes 19 (38.0%) 14 (33.3%)
Brain metastasis
No 43 (86.0%) 33 (78.6%) 0.509
Yes 7 (14.0%) 9 (21.4%)
Liver metastasis
No 44 (88.0%) 40 (95.2%) 0.392
Yes 6 (12.0%) 2 (4.8%)
Pleura metastasis
No 36 (72.0%) 33 (78.6%) 0.629
Yes 14 (28.0%) 9 (21.4%)
Lymph metastasis
No 28 (56.0%) 18 (42.9%) 0.295
Yes 22 (44.0%) 24 (57.1%)